As markets grapple with changing macroeconomic dynamics, elevated valuations for growth stocks, and increased volatility, the ...
India and the 27-nation European Union (EU) bloc will start the tenth round of negotiations for a proposed free trade agreement from Monday in Brussels amid Trump tariff threats, according to an ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...
Against this volatile backdrop, EU- India FTA negotiations reopened in 2022 after a 9-year hiatus and are accompanied by significant geopolitical imperatives. The upcoming commission visit will pave ...
The two sides will take stock of “where we are and how we can push forward those negotiations” for the FTA, the official said. Describing India as a “relatively closed” market, especially ...
Credit: Elena Vafina via Getty Images. Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ farnesoid X receptor (FXR) agonist ...
“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will provide an ...
Organovo Holdings, Inc. announced that it will be acquired by Eli Lilly and Company, which includes Organovo's FXR program and its lead asset, FXR314, aimed at treating inflammatory bowel disease ...
Eli Lilly is buying Organovo’s farnesoid X receptor (FXR) agonist program, which includes a drug in Phase 2 development for ulcerative colitis and metabol ...
India and the UK resumed FTA talks aiming to triple bilateral trade, addressing tariffs and business mobility while protecting each other's sensitivities. India and the UK on Monday resumed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback